Asia-Pacific Roundup: India’s CDSCO halves clinical trial review timelines
RoundupsNick Paul Taylor
AsiaBiologics/ biosimilars/ vaccinesMedical DevicesOceaniaPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyRoundupsNick Paul TaylorAsiaBiologics/ biosimilars/ vaccinesMedical DevicesOceaniaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy